Precigen, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
PGEN Nasdaq 2836 precigen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Precigen, Inc.

4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike - Oct 2nd, 2026 4:57 am
UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13% - Oct 1st, 2026 9:16 am
Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock? - Oct 1st, 2026 1:35 am
NVO's Ozempic Outshines LLY's Mounjaro in Lowering Cardiovascular Risk - Sep 30th, 2026 11:34 am
uniQure Plunges on Additional Data From Huntington's Disease Study - Sep 30th, 2026 10:47 am
PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential? - Sep 30th, 2026 9:08 am
IOVA Stock Hits 52-Week High on Raised Revenue Outlook for 2026 - Sep 30th, 2026 7:22 am
Here's Why You Should Add URGN Stock to Your Portfolio Now - Sep 30th, 2026 7:11 am
AbbVie Wins FDA Nod for New Parkinson's Disease Drug Juvmo - Sep 29th, 2026 9:37 am
KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears - Sep 29th, 2026 8:13 am
Merck Inks $2.1B Deal With Chinese Biotech to Expand Oncology Pipeline - Sep 29th, 2026 8:12 am
Mirum's Brelovitug Meets Goal in Phase III AZURE-1 Study in HDV - Sep 29th, 2026 7:20 am
KROS Begins Dosing in Phase II Study With Rinvatercept in DMD - Sep 29th, 2026 7:17 am
Acadia's Daybue Patent Allowance Extends U.S. Protection to March 2041 - Sep 29th, 2026 7:06 am
Precigen (PGEN) Gets FDA Recognition. Can it Cut the Cost of Developing New Drugs? - Sep 28th, 2026 7:58 pm
FDA Expands Merck's Welireg Label for a New Kidney Cancer Indication - Sep 28th, 2026 9:04 am
MIRM Secures FDA Nod for an Ultra-Rare Bone Disorder Therapy - Sep 28th, 2026 8:45 am
LLY's Olumiant Gets FDA Nod for Expanded Use in Pediatric Hair Loss - Sep 28th, 2026 8:03 am
Precigen (PGEN) Gains FDA Platform Backing, Is The Stock Still Cheap? - Sep 26th, 2026 11:09 am
MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today? - Sep 25th, 2026 12:37 pm